Original ArticleUnraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects
Section snippets
Mesenchymal Stromal Cells Inhibit Immune T-Cell Proliferation - MLR Inhibition
The MLR is an in vitro method to assay for proliferation of responder CD4 + T cells, in the presence of an allogeneic T-cell population [25]. Di Nicola et al [18] first explored the in vitro mechanism of MSC immunomodulatory effect on T cells by coculturing T cells from 2 donor populations in vitro in a 1-way MLR assay and adding MSCs. In the presence of MSCs, the CD4 allo-T-cell proliferation response was diminished by more than 60%. However, to further ask whether MSC–T-cell contact was
Transforming Growth Factor β
Mesenchymal stromal cell's immunomodulatory abilities to suppress both CD4 + and CD8 + T-cell proliferation, with or without direct contact with MSCs in the MLR, could be abrogated by the addition of monoclonal antibodies that neutralized distinct cytokines produced by MSCs hereby elucidating the role of specific cytokines in MSC immunomodulation. Transforming growth factor β, a known MSC-secreted protein regulating cell proliferation and differentiation, plays a major role during immune
Hepatocyte Growth Factor
Hepatocyte growth factor is a cellular growth factor produced by MSCs that plays a major role during organogenesis and angiogenesis and has been recently shown to have regenerative properties in myelodegenerative diseases [36]. In a murine model of allogeneic hematopoietic stem cell transplantation, HGF treatment was shown to ameliorate acute GVHD, suggesting that HGF also had immunomodulatory effects [37]. Indeed, using the similar MLR in vitro model described above, HGF blocking antibodies
Prostaglandin E2
Prostaglandins have been long associated with inflammation and targeted by cyclooxygenase (COX) inhibitors to treat inflammatory diseases. However, one of these prostaglandins, prostaglandin E2 (PGE2), has been recognized as having anti-inflammatory [38] and immunomodulatory effects [39]. Interestingly, PGE2 was identified by Aggarwal and Pittenger [20] as a key cytokine secreted in the culture medium of hMSCs exposed to different populations of immune cells. In cocultures of HLA-unmatched
Interleukin 10 and Interleukin 1 Receptor Antagonist
Interleukin 10 is a cytokine primarily expressed by monocytes, Th2 lymphocytes, and Tregs. Interleukin 10 has multiple immunoregulatory and anti-inflammatory effects; indeed, it down-regulates macrophage expression of MHC class II and Th1 inflammatory cytokines. In an MLR study on MSC paracrine factors associated with inhibition of T-cell proliferation, Nasef et al [26] demonstrated increased hMSC IL-10 gene expression, which was T-cell contact dependent. The role of IL-10 in MSC-mediated
Interleukin 6
Interleukin 6 has long been recognized as an interleukin having both proinflammatory and anti-inflammatory properties depending on the source of synthesis. Interleukin 6 is constitutively expressed by hMSCs in the BM niche during hematopoiesis, but its expression is up-regulated in the presence of IL-1α[49]. Subsequently, parallel immune studies showed that mMSCs derived from IL-6 knockout (IL-6 −/−) mice could not strongly suppress allo-T-cell proliferation in an MLR assay. These data
Leukocyte Inhibitory Factor
Leukocyte inhibitory factor (LIF), similar to IL-6, is constitutively expressed by hMSCs. Leukocyte inhibitory factor expression can be further increased, up to 7-fold, in MSCs cocultured with CD3 + lymphocytes. Furthermore, in an MLR assay, LIF neutralizing antibody restored lymphocyte proliferation and decreased Foxp3 Treg ratio [53]. Whether the LIF effect is direct or indirect needs further analysis.
HLA-G
HLA-G is a nonclassical HLA class I molecule, which has been identified in both membrane bound and soluble forms [54]. HLA-G was originally identified at the feto-maternal interface but is more recently shown to be a key immunomodulatory factor playing a role in both innate and adaptive immune responses [54], [55], [56]. Nasef et al [26] first identified messenger RNA expression of HLA-G in hMSCs cocultured in an MLR, resulting in a significant inhibitory effect on lymphocyte proliferation. In
Indoleamine 2,3-Dioxygenase
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that catalyzes the degradation of the essential amino acid l-tryptophan. Indoleamine 2,3-dioxygenase expression by DCs is induced by IFN-γ and results in increased tryptophan catabolism, which is an immunosuppressive effector pathway that inhibits T-cell responses to alloantigens in vivo [58], [59]. Based on these findings, Meisel et al [60] investigated whether hMSCs exhibited IFN-γ–inducible IDO activity and whether this mechanism contributes to
Nitric Oxide
Nitric oxide synthase (NOS) catalyzes the production of nitric oxide, which has been recognized as a key player in the mechanism of MSC-mediated immunosuppression [61]. The gene of interest coding for inducible NOS (iNOS) and is inducible in both MSCs and macrophages, playing a major role in immune regulation. In the MLR in vitro assay, mMSC–T cell coculture was associated with NOS production by mMSCs but not by T cells, and the addition of a specific inhibitor of NOS reversed T-cell
Hemeoxygenase, an Enzyme Involved in Heme Catabolism
There are 3 isoforms of hemeoxygenase enzyme. Hemeoxygenase 1 (HO-1) is an inducible isoform in response to oxidative stress and inflammatory cytokines, and its expression may be protective against oxidative damage. Rat MSCs that have been shown to inhibit T-cell proliferation in vitro express both HO-1 and iNOS [63], and inhibition of both HO-1 and iNOS was required to mitigate the suppressive abilities of rat MSCs on rat T-cell proliferation. Interestingly, for hMSCs, only the inhibition of
Galectins
Galectins are lectins in the β-galactoside–binding family expressed on T-cell surfaces, mediating T-cell suppression and apoptosis. Galectin 1 (Gal-1) is highly expressed both at the gene and protein levels in hMSCs cocultured in an MLR system. Furthermore, Gal-1 knockdown restores IFN-γ production as well as proliferation of alloreactive T cells [65]. The inflammatory cytokines IFN-γ, TNF-α, IL-2, and IL-12 in the MLR coculture supernatant were decreased in the presence of hMSCs, suppressing a
Tumor Necrosis Factor α–Stimulated Gene 6
Tumor necrosis factor α–stimulated gene 6 (TSG-6) is a multifunctional protein involved in inflammation, extracellular matrix formation, cell migration, and development. Tumor necrosis factor α–stimulated gene 6 is known for having strong anti-inflammatory effects by competing for CD44 receptor on leukocyte binding to hyaluronan during neutrophil migration into tissues [67]. Tumor necrosis factor α–stimulated gene 6 was originally found to be secreted by dermal fibroblasts incubated with TNF-α
Extracellular Vesicles—Exosomes and Microvesicles
The paracrine factors derived from MSCs may be delivered to target cells by extracellular vesicles (EVs), which are now recognized as relevant means of intercellular communication that MSC may use to impact immune cell function [71], [72], [73]. Extracellular vesicles can be either classified as exosomes, which are 50 to 100 nm in diameter containing cytoplasmic content and are secreted through vesicular fusion with the plasma membrane [74]. The other type of EV is a microvesicle, which is 0.1
Conclusion
Upon review of the main MSC-derived paracrine factors with immunoregulatory properties, we should emphasize that only a few of these are constitutively expressed such as LIF and IL-6 (Table). Indeed, secretion of most of these MSC paracrine factors is influenced by host environmental factors, and MSCs mostly acquire their immunomodulatory properties upon exposure to inflammation [80], [81]. Mesenchymal stromal cells may have direct paracrine immunomodulatory effects on the adaptive immune
Conflict of Interest
The authors declare to hold no conflict of interest with the publication of the results included in this manuscript.
References (82)
- et al.
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation
Blood
(2003) - et al.
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Blood
(2001) - et al.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Cytotherapy
(2006) - et al.
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
Exp Hematol
(2002) - et al.
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Blood
(2002) - et al.
Human mesenchymal stem cells modulate allogeneic immune cell responses
Blood
(2005) - et al.
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
Blood
(2005) - et al.
Macrophage proinflammatory activation and deactivation: a question of balance
Adv Immunol
(2010) - et al.
Mesenchymal stem cell–educated macrophages: a novel type of alternatively activated macrophages
Exp Hematol
(2009) - et al.
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6
Cytotherapy
(2009)
Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression
Cell Immunol
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Blood
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells
Cytotherapy
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Trends Immunol
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
Blood
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Blood
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
Blood
The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells
Blood
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Blood
TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity
Cytokine Growth Factor Rev
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6
Cell Stem Cell
MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6
Biochem Biophys Res Commun
Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling
Immunol Lett
Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b + splenocytes
Gastroenterology
Multilineage potential of adult human mesenchymal stem cells
Science
Multilineage cells from human adipose tissue: implications for cell-based therapies
Tissue Eng
Mesenchymal progenitor cells in human umbilical cord blood
Br J Haematol
Endometrial regenerative cells: a novel stem cell population
J Transl Med
Multipotent mesenchymal stem cells from adult human synovial membrane
Arthritis Rheum
Growth characteristics and immunomodulatory properties of mesenchymal stem cells depend on the tissue of origin
Transfusion
Clonal analysis of multipotent stromal cells derived from CD271 + bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression
Haematologica
Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B– but not JNK-dependent mechanism
Am J Physiol Cell Physiol
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing
PLoS One
Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections
BMC Cell Biol
The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury
Br J Radiol
Role of mesenchymal stem cells (MSC) in allogeneic transplantation: early phase I clinical results
Blood
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
Scand J Immunol
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
J Biomed Sci
The immunosuppressive properties of mesenchymal stem cells
Transplantation
Human mesenchymal stem cells license adult CD34 + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway
J Immunol
Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice
Diabetologia
Cited by (133)
Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
2023, Journal of Advanced ResearchCRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy
2022, Regenerative TherapyCitation Excerpt :Since all of gene-edited UC-MSCs in this study were confirmed to meet the definition, it was suggested that knock-in/knock-out processes, including CRISPR/Cas9 system with AAV, do not affect the characteristics of UC-MSCs. UC-MSCs have been reported to exert inhibitory effects on T cells by secreting humoral factors, such as TGFβ, IL-10, and IDO [28], and we conducted MLR assays to see if B2M(−)/BG(+) AAV and B2M(−)/BG(+) LV with the introduced B2M-HLA-G fusion gene retain similar immunosuppressive potentials. The immunosuppressive effects of bone marrow-derived MSCs against steroid-refractory GVHD have been reported in 2004 [5].
Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs
2023, Nature Communications